Stada’s Acquisition Spree Continues With Deal For Ukrainian Probiotics Player
Executive Summary
Germany's Stada will gain a range of probiotics and other OTC brands through the acquisition of Ukraine's Biopharma. The deal is Stada's third in the space of just one month.
You may also be interested in...
Stada UK Head On COVID-19 Impact, Local Growth Strategy And OTC Brand Innovation
Exclusive: HBW Insight talks to Stada executive vice-president Roger Scarlett-Smith on the progress of the company's ambitious growth strategy, the impact of the coronavirus and its new innovation centre in Yorkshire, England.
Stada Grabs GSK Brands In EU
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.
Stada Grabs GSK Brands In Key EU Markets
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales in excess of €100m.